propiconazole has been researched along with Lymphoma, Mantle-Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenberg, PB; Hafeez, S; Hunter, A; Mancini, A; Mega, J; Siegel, C | 1 |
| Annunziata, J; Hirji, SH; Kazim, M; Maeng, MM; Soderquist, C; Tooley, AA | 1 |
| Baillif, S; Marin, L; Martel, A; Nahon, S; Peyrade, F; Toumi, E | 1 |
| Abou, Z; Chi, L; Dabaja, BS; Esmaeli, B; Fanale, MA; Fayad, L; Fowler, N; Hagemeister, F; Lee, HJ; Milgrom, SA; Nastoupil, L; Neelapu, S; Oki, Y; Pinnix, CC; Rodriguez, MA; Romaguera, J; Samaniego, F; Smith, GL; Turturro, F; Wang, M; Westin, J | 1 |
| Cox, MC; Lionetto, L; Mannino, G; Naso, V; Simmaco, M; Spiriti, MA | 1 |
5 other study(ies) available for propiconazole and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Case Report: Ocular Manifestation of Mantle Cell Lymphoma.
Topics: Adult; Aged; Conjunctival Diseases; Eye; Humans; Lymphoma, Mantle-Cell; Male; Orbit; Prognosis; Tomography, X-Ray Computed | 2022 |
Orbital marginal cell lymphoma and mantle cell lymphoma subclone in patient with monoclonal gammopathy of unknown significance.
Topics: Adult; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Orbit; Paraproteinemias | 2021 |
[Orbital mantle cell lymphoma succesfully treated by Bcl-2 inhibitor: Report of a case].
Topics: Adult; Exophthalmos; Humans; Lymphoma, Mantle-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Orbit | 2021 |
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Topics: Adult; Aged; Cohort Studies; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Orbit; Prognosis; Radiotherapy; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome | 2017 |
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
Topics: Aged; Antineoplastic Agents; Central Nervous System Neoplasms; Chromatography, Liquid; Humans; Lenalidomide; Lymphoma, Mantle-Cell; Magnetic Resonance Imaging; Male; Orbit; Tandem Mass Spectrometry; Thalidomide | 2011 |